For citations:
Tatarsky B.A., Kazennova N.V., Napalkov D.A. The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality. Rational Pharmacotherapy in Cardiology. 2020;16(2):301-306. (In Russ.) https://doi.org/10.20996/1819-6446-2020-04-17
Email this article 